Cheshire, UK -- (MARKET WIRE) -- January 4, 2007 --
PROTHERICS PLC
NOTIFICATION OF INTERESTS OF DIRECTORS
London, UK; Brentwood, TN, US; 4 January 2007: Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that following completion of the Cash Placing, the
Placing and Open Offer, the Glenveigh Licence and the MacroMed Acquisition and
as a result of the Directors taking up all of their entitlements under the
Placing and Open Offer at a price of 65 pence per share, the following
directors' holdings in Ordinary Shares have changed as set out below:
Number of Ordinary Shares Number of Ordinary Shares Percentage of issued
taken up under the Open following the Open Offer share capital
Offer
S M Wallis 62,965 566,689 0.17
A J Heath 43,312 389,810 0.11
B M Riley 3,752 33,771 0.01
J C Christie 3,542 31,885 0.01
J R Brown 2,500 22,500 0.01
Protherics current issued Ordinary Share capital is 338,976,174
Terms used in this announcement shall have the same meaning as those used in the
Company's prospectus dated 7 December 2006.
ENDS
For further information contact:
Protherics PLC
Barry Riley, CFO +44 (0) 1928 518 000
Julie Vickers, Company Secretary +44 (0) 1928 518 010
This information is provided by RNS
The company news service from the London Stock Exchange